Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Castellani paint
- Development stage
- Phase 2
- Lead developer
- Stratus Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Castellani paint is a topical anti-infective solution traditionally composed of phenol, resorcinol, boric acid, acetone, and basic fuchsin. It is primarily used for the treatment of fungal skin infections, such as tinea pedis (athlete's foot) and tinea cruris (jock itch), as well as bacterial infections like erythrasma. The solution acts as an antiseptic, disinfectant, and antifungal agent. The "modified" version typically excludes basic fuchsin to avoid staining. Stratus Pharmaceuticals is a key developer and manufacturer of this product, which has been a staple in dermatological practice for decades due to its broad-spectrum antimicrobial properties.
- Brand names
- Castellani Paint
- Other names
- Carbol-Fuchsin SolutionCastellani's Solution
Beyond the preview
Go deeper on Castellani paint.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Castellani paint.